TRPC6 and pulmonary arterial hypertension: TRPC6 has been embraced as a promising therapeutic target for a variety of diseases including gastric cancer [32], pulmonary hypertension [33], and heart disease [4], and a variety of new substances targeting TRPC6 are being developed (e.g., [32,34]).